Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» ASH: Seattle Genetics CEO sees a big new Adcetris market, but one analyst has some doubts
ASH: Seattle Genetics CEO sees a big new Adcetris market, but one analyst has some doubts
ASH: Seattle Genetics CEO sees a big new Adcetris market, but one analyst has some doubts
Submitted by
admin
on December 11, 2017 - 11:35am
Source:
Fierce Pharma
News Tags:
ASH17
Seattle Genetics
Adcetris
Hodgkin's lymphoma
Headline:
ASH: Seattle Genetics CEO sees a big new Adcetris market, but one analyst has some doubts
Do Not Allow Advertisers to Use My Personal information
